XML 49 R39.htm IDEA: XBRL DOCUMENT v3.8.0.1
Contracts in Process (Tables)
 9 Months Ended
Sep. 29, 2017
Contracts in Process [Abstract]  
Components of Contracts in Process
The components of contracts in process are presented in the table below.
September 29,
2017
December 31,
2016
(in millions)
Unbilled contract receivables, gross
$
1,965
 
$
2,020
 
Unliquidated progress payments
 
(710
)
 
(827
)
Unbilled contract receivables, net
 
1,255
 
 
1,193
 
Inventoried contract costs, gross
 
1,101
 
 
1,065
 
Unliquidated progress payments
 
(83
)
 
(203
)
Inventoried contract costs, net
 
1,018
 
 
862
 
Total contracts in process
$
2,273
 
$
2,055
 
General and Administrative, Independent Research and Development and Bid and Proposal Costs
The table below presents a summary of G&A, IRAD and B&P costs included in inventoried contract costs and the changes to them, including amounts charged to cost of sales by the Company’s U.S. Government contractor businesses for the periods presented.
Third Quarter Ended
Year-to-Date Ended
September 29,
2017
September 23,
2016
September 29,
2017
September 23,
2016
(in millions)
Amounts included in inventoried contract costs at beginning of the period
$
174
 
$
163
 
$
173
 
$
137
 
Contract costs incurred:
 
 
 
 
 
 
 
 
 
 
 
 
IRAD and B&P
 
89
 
 
76
 
 
246
 
 
213
 
Other G&A(1)
 
219
 
 
201
 
 
671
 
 
611
 
Total
 
308
 
 
277
 
 
917
 
 
824
 
Amounts charged to cost of sales
 
(303
)
 
(270
)
 
(911
)
 
(791
)
Amounts included in inventoried contract costs at end of the period
$
179
 
$
170
 
$
179
 
$
170
 
 
 
(1)
Amounts include severance and restructuring related costs of $31 million and $4 million for the quarterly periods ended September 29, 2017 and September 23, 2016, respectively, and $54 million and $9 million for the year-to-date periods ended September 29, 2017 and September 23, 2016, respectively.
Selling, General and Administrative Expenses and Research and Development Expenses
The table below presents a summary of selling, general and administrative expenses and research and development expenses for the Company’s commercial businesses, which are expensed as incurred and included in cost of sales on the unaudited condensed consolidated statements of operations.
Third Quarter Ended
Year-to-Date Ended
September 29,
2017
September 23,
2016
September 29,
2017
September 23,
2016
(in millions)
Selling, general and administrative expenses
$
71
 
$
53
 
$
205
 
$
164
 
Research and development expenses
 
15
 
 
16
 
 
47
 
 
40
 
Total
$
86
 
$
69
 
$
252
 
$
204